Cargando...

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab

We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Transl Allergy
Main Authors: de Brito, Marianne, Huebner, Gisela, Murrell, DedeeF, Bullpitt, Peter, Hartmann, Karin
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149008/
https://ncbi.nlm.nih.gov/pubmed/30258566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-018-0222-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!